All these data indicate that CD4+ T-cells play a regulatory role on microglial cells during ALS progression, providing supportive neuroprotection by favouring the acquisition of the M2-like phenotype by microglial cells. This evidence concerns the gene CD4 and amyotrophic lateral sclerosis.